Target Name: TEDC2
NCBI ID: G80178
Review Report on TEDC2 Target / Biomarker Content of Review Report on TEDC2 Target / Biomarker
TEDC2
Other Name(s): uncharacterized protein C16orf59 | C16orf59 | TEDC2_HUMAN | tubulin epsilon and delta complex 2 | Tubulin epsilon and delta complex protein 2 | Tubulin epsilon and delta complex 2

Protein C16orf59: A Potential Drug Target and Biomarker

Cancer is one of the leading causes of human mortality, and the development of new treatments is crucial in reducing cancer incidence and mortality. One promising approach to combatting cancer is the identification of potential drug targets and biomarkers. In this article, we focus on an uncharacterized protein called C16orf59 and its potential as a drug target and biomarker in the context of cancer.

C16orf59: A Putative Drug Target

The protein C16orf59 is a gene that encodes a protein with unique features. It has a calculated molecular weight of 13.9 kDa and a predicted localization in the cell's cytoplasm. C16orf59 is expressed in various tissues, including brain, heart, liver, and muscle. It is also highly expressed in human cancer tissues, making it an attractive target for cancer therapies.

Several studies have suggested that C16orf59 may play a role in cancer development. For instance, overexpression of C16orf59 has been shown to promote the growth and metastasis of various cancer types, including breast, lung, and colorectal cancer. Additionally, C16orf59 has been associated with cancer-related inflammation, which is a known predictor of cancer outcomes.

C16orf59 as a Biomarker

The detection of cancer biomarkers is critical for the diagnosis and prognosis of cancer. C16orf59 is a potential biomarker for various types of cancer, including breast, lung, and colorectal cancer. Its expression has been shown to be associated with the severity of cancer-related inflammation, as previously discussed.

In addition to its potential as a biomarker, C16orf59 has also been shown to be a potential drug target. Its unique features and its association with cancer-related inflammation make it an attractive target for small molecules or antibodies that can inhibit its activity.

Conclusion

In conclusion, C16orf59 is an uncharacterized protein that has unique features and has been associated with various aspects of cancer development, including cancer-related inflammation. Its potential as a drug target and biomarker make it an attractive target for new cancer therapies. Further research is needed to fully understand its role in cancer and to develop effective treatments.

Protein Name: Tubulin Epsilon And Delta Complex 2

Functions: Acts as a positive regulator of ciliary hedgehog signaling. Required for centriole stability

The "TEDC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TEDC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TEDC2-AS1 | TEDDM1 | TEF | TEFM | TEK | TEKT1 | TEKT2 | TEKT3 | TEKT4 | TEKT4P1 | TEKT4P2 | TEKT5 | TEKTIP1 | TELO2 | Telomerase holoenzyme complex | TEN1 | TEN1-CDK3 | Teneurin | TENM1 | TENM2 | TENM2-AS1 | TENM3 | TENM3-AS1 | TENM4 | TENT2 | TENT4A | TENT4B | TENT5A | TENT5B | TENT5C | TENT5C-DT | TENT5D | TEP1 | TEPP | TEPSIN | TERB1 | TERB2 | TERC | TERF1 | TERF1P3 | TERF2 | TERF2IP | TERLR1 | TERT | TES | TESC | TESK1 | TESK2 | TESMIN | TESPA1 | TET1 | TET2 | TET2-AS1 | TET3 | Tetraspanin | TEX10 | TEX101 | TEX11 | TEX12 | TEX13A | TEX13B | TEX13C | TEX14 | TEX15 | TEX19 | TEX2 | TEX21P | TEX22 | TEX26 | TEX261 | TEX264 | TEX28 | TEX29 | TEX30 | TEX33 | TEX35 | TEX36 | TEX36-AS1 | TEX37 | TEX38 | TEX41 | TEX43 | TEX44 | TEX45 | TEX46 | TEX47 | TEX48 | TEX49 | TEX50 | TEX52 | TEX53 | TEX55 | TEX56P | TEX9 | TF | TFAM | TFAMP1 | TFAP2A | TFAP2A-AS1 | TFAP2A-AS2